Bulls vs Bears
Click to unlock major analysts' bullish and bearish positions by joining Benzinga Edge.
Itron Inc has a consensus price target of $122.53 based on the ratings of 18 analysts. The high is $150 issued by Roth Capital on July 22, 2025. The low is $68 issued by JP Morgan on December 12, 2023. The 3 most-recent analyst ratings were released by Stephens & Co., TD Cowen, and JP Morgan on May 20, 2026, April 29, 2026, and April 16, 2026, respectively. With an average price target of $124.33 between Stephens & Co., TD Cowen, and JP Morgan, there's an implied 52.84% upside for Itron Inc from these most-recent analyst ratings.
1calculated from analyst ratings
The latest price target for Itron (NASDAQ:ITRI) was reported by Stephens & Co. on May 20, 2026. The analyst firm set a price target for $130.00 expecting ITRI to rise to within 12 months (a possible 59.80% upside). 19 analyst firms have reported ratings in the last year.
The latest analyst rating for Itron (NASDAQ:ITRI) was provided by Stephens & Co., and Itron reiterated their overweight rating.
The last upgrade for Itron Inc happened on February 18, 2026 when Baird raised their price target to $128. Baird previously had a neutral for Itron Inc.
The last downgrade for Itron Inc happened on February 17, 2026 when Guggenheim changed their price target from N/A to N/A for Itron Inc.
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Itron, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Itron was filed on May 20, 2026 so you should expect the next rating to be made available sometime around May 20, 2027.
While ratings are subjective and will change, the latest Itron (ITRI) rating was a reiterated with a price target of $130.00 to $130.00. The current price Itron (ITRI) is trading at is $81.35, which is out of the analyst’s predicted range.
Browse analyst ratings and price targets on all stocks.
Data & APIs: Benzinga APIs · Stock News API · Analyst Ratings API · Company Logo API
Market data provided by Benzinga APIs
A newsletter built for market enthusiasts by market enthusiasts. Top stories, top movers, and trade ideas delivered to your inbox every weekday before and after the market closes.
Click to unlock major analysts' bullish and bearish positions by joining Benzinga Edge.

| Buy Now | Get Alert | ||||||
|---|---|---|---|---|---|---|---|
| 05/20/2026 | Buy Now | 59.8% | Stephens & Co. | $130 → $130 | Reiterates | Overweight → Overweight | Get Alert |
| 04/29/2026 | Buy Now | 59.8% | TD Cowen | $145 → $130 | Maintains | Buy | Get Alert |
| 04/16/2026 | Buy Now | 38.91% | JP Morgan | $133 → $113 | Maintains | Overweight | Get Alert |
| 04/16/2026 | Buy Now | 65.95% | Oppenheimer | $133 → $135 | Maintains | Outperform | Get Alert |
| 03/06/2026 | Buy Now | 52.43% | Needham | → $124 | Initiates | → Buy | Get Alert |
| 02/18/2026 | Buy Now | 63.49% | Oppenheimer | $125 → $133 | Maintains | Outperform | Get Alert |
| 02/18/2026 | Buy Now | 57.34% | Baird | $118 → $128 | Upgrade | Neutral → Outperform | Get Alert |
| 02/17/2026 | Buy Now | — | Guggenheim | — | Downgrade | Buy → Neutral | Get Alert |
| 02/13/2026 | Buy Now | — | Guggenheim | — | Downgrade | Buy → Neutral | Get Alert |
| 01/27/2026 | Buy Now | 53.66% | Oppenheimer | $145 → $125 | Maintains | Outperform | Get Alert |
| 01/05/2026 | Buy Now | 59.8% | Johnson Rice | → $130 | Upgrade | Accumulate → Buy | Get Alert |
| 11/04/2025 | Buy Now | — | Argus Research | — | Downgrade | Buy → Hold | Get Alert |
| 10/31/2025 | Buy Now | 45.05% | Baird | $137 → $118 | Downgrade | Outperform → Neutral | Get Alert |
| 10/16/2025 | Buy Now | 90.53% | JP Morgan | $145 → $155 | Maintains | Overweight | Get Alert |
| 10/07/2025 | Buy Now | 59.8% | Stephens & Co. | $130 → $130 | Reiterates | Equal-Weight → Equal-Weight | Get Alert |
| 07/31/2025 | Buy Now | 78.24% | JP Morgan | $128 → $145 | Upgrade | Neutral → Overweight | Get Alert |
| 07/22/2025 | Buy Now | 84.39% | Roth Capital | $130 → $150 | Maintains | Buy | Get Alert |
| 07/22/2025 | Buy Now | 57.34% | JP Morgan | $118 → $128 | Maintains | Neutral | Get Alert |
| 07/14/2025 | Buy Now | 90.53% | Guggenheim | $133 → $155 | Maintains | Buy | Get Alert |
| 05/05/2025 | Buy Now | 48.74% | Piper Sandler | $124 → $121 | Maintains | Neutral | Get Alert |
| 04/17/2025 | Buy Now | 63.49% | Guggenheim | $133 → $133 | Reiterates | Buy → Buy | Get Alert |
| 02/27/2025 | Buy Now | 63.49% | Guggenheim | $135 → $133 | Maintains | Buy | Get Alert |
| 02/27/2025 | Buy Now | 52.43% | Piper Sandler | $119 → $124 | Maintains | Neutral | Get Alert |
| 02/26/2025 | Buy Now | 62.26% | Canaccord Genuity | $130 → $132 | Maintains | Buy | Get Alert |
| 02/26/2025 | Buy Now | 61.03% | Oppenheimer | $124 → $131 | Maintains | Outperform | Get Alert |
| 11/06/2024 | Buy Now | 65.95% | Guggenheim | $128 → $135 | Maintains | Buy | Get Alert |
| 11/01/2024 | Buy Now | 67.18% | TD Cowen | $125 → $136 | Maintains | Buy | Get Alert |
| 11/01/2024 | Buy Now | 59.8% | Roth MKM | $125 → $130 | Maintains | Buy | Get Alert |
| 11/01/2024 | Buy Now | 46.28% | Piper Sandler | $110 → $119 | Maintains | Neutral | Get Alert |
| 11/01/2024 | Buy Now | 52.43% | Oppenheimer | $120 → $124 | Maintains | Outperform | Get Alert |
| 11/01/2024 | Buy Now | 62.26% | Baird | $123 → $132 | Maintains | Outperform | Get Alert |
| 09/27/2024 | Buy Now | 61.03% | Janney Montgomery Scott | → $131 | Initiates | → Buy | Get Alert |
| 08/21/2024 | Buy Now | 53.66% | Roth MKM | $125 → $125 | Maintains | Buy | Get Alert |
| 08/05/2024 | Buy Now | 35.22% | Stephens & Co. | $110 → $110 | Reiterates | Equal-Weight → Equal-Weight | Get Alert |
| 08/02/2024 | Buy Now | 53.66% | Roth MKM | $122 → $125 | Maintains | Buy | Get Alert |
| 08/02/2024 | Buy Now | 51.2% | Baird | $115 → $123 | Maintains | Outperform | Get Alert |
| 07/22/2024 | Buy Now | 35.22% | Piper Sandler | $109 → $110 | Maintains | Neutral | Get Alert |
| 07/17/2024 | Buy Now | 37.68% | Oppenheimer | $110 → $112 | Maintains | Outperform | Get Alert |
| 07/16/2024 | Buy Now | 37.68% | JP Morgan | $104 → $112 | Maintains | Neutral | Get Alert |
| 07/16/2024 | Buy Now | 49.97% | Roth MKM | $112 → $122 | Maintains | Buy | Get Alert |
| 07/11/2024 | Buy Now | 59.8% | Guggenheim | → $130 | Upgrade | Neutral → Buy | Get Alert |
| 06/20/2024 | Buy Now | 47.51% | Canaccord Genuity | $115 → $120 | Maintains | Buy | Get Alert |
| 05/21/2024 | Buy Now | 33.99% | Piper Sandler | $109 → $109 | Downgrade | Overweight → Neutral | Get Alert |
| 05/06/2024 | Buy Now | 35.22% | Stephens & Co. | $85 → $110 | Maintains | Equal-Weight | Get Alert |
| 05/03/2024 | Buy Now | 41.36% | Canaccord Genuity | $105 → $115 | Maintains | Buy | Get Alert |
| 05/03/2024 | Buy Now | 41.36% | TD Cowen | $110 → $115 | Maintains | Buy | Get Alert |
| 05/03/2024 | Buy Now | 37.68% | Roth MKM | $102 → $112 | Maintains | Buy | Get Alert |
| 05/03/2024 | Buy Now | 33.99% | Piper Sandler | $103 → $109 | Reiterates | Overweight → Overweight | Get Alert |
| 05/03/2024 | Buy Now | 35.22% | Oppenheimer | $100 → $110 | Maintains | Outperform | Get Alert |
| 04/23/2024 | Buy Now | 25.38% | Roth MKM | → $102 | Maintains | Buy | Get Alert |
| 04/11/2024 | Buy Now | 26.61% | Piper Sandler | $105 → $103 | Maintains | Overweight | Get Alert |
| 03/13/2024 | Buy Now | 35.22% | TD Cowen | $107 → $110 | Maintains | Outperform | Get Alert |
| 03/13/2024 | Buy Now | 41.36% | Baird | $108 → $115 | Maintains | Outperform | Get Alert |
| 03/13/2024 | Buy Now | 13.09% | JP Morgan | $77 → $92 | Maintains | Neutral | Get Alert |
| 02/27/2024 | Buy Now | 29.07% | Piper Sandler | $91 → $105 | Maintains | Overweight | Get Alert |
| 02/27/2024 | Buy Now | 32.76% | Baird | $68 → $108 | Upgrade | Neutral → Outperform | Get Alert |
| 01/19/2024 | Buy Now | -0.43% | Oppenheimer | → $81 | Upgrade | Perform → Outperform | Get Alert |
| 01/04/2024 | Buy Now | — | Raymond James | — | Downgrade | Outperform → Market Perform | Get Alert |
| 12/19/2023 | Buy Now | 11.86% | Piper Sandler | $72 → $91 | Upgrade | Neutral → Overweight | Get Alert |
| 12/12/2023 | Buy Now | -16.41% | JP Morgan | → $68 | Upgrade | Underweight → Neutral | Get Alert |
| 12/05/2023 | Buy Now | 0.8% | Roth MKM | → $82 | Initiates | → Buy | Get Alert |
| 12/01/2023 | Buy Now | -16.41% | Canaccord Genuity | → $68 | Initiates | → Hold | Get Alert |
| 11/03/2023 | Buy Now | -11.49% | Piper Sandler | $71 → $72 | Maintains | Neutral | Get Alert |
| 10/19/2023 | Buy Now | -20.1% | JP Morgan | $72 → $65 | Maintains | Underweight | Get Alert |
| 10/06/2023 | Buy Now | -12.72% | Piper Sandler | $63 → $71 | Maintains | Neutral | Get Alert |
| 09/22/2023 | Buy Now | -1.66% | Seaport Global | → $80 | Initiates | → Buy | Get Alert |
| 09/11/2023 | Buy Now | — | Guggenheim | — | Initiates | → Neutral | Get Alert |
| 08/18/2023 | Buy Now | 0.8% | Argus Research | → $82 | Upgrade | Hold → Buy | Get Alert |
| 08/04/2023 | Buy Now | 16.78% | TD Cowen | $85 → $95 | Maintains | Outperform | Get Alert |
| 08/04/2023 | Buy Now | -7.81% | Baird | $63 → $75 | Maintains | Neutral | Get Alert |
| 07/12/2023 | Buy Now | — | Raymond James | — | Downgrade | Strong Buy → Outperform | Get Alert |